Transporting Antitumor Drug Tamoxifen and Its Metabolites, 4-Hydroxytamoxifen and Endoxifen by Chitosan Nanoparticles
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference40 articles.
1. Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer;C Jordan V;Br J Pharmacol,2006
2. The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer;M Spears;Expert Opin Ther Targets,2009
3. Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer;J Brauch;Eur J Cancer,2009
4. Pharmacologic treatment of male breast cancer;G Hayes T;Expert Opin Pharmacother,2009
5. The emerging role of aromatase inhibitors in the adjuvant management of breast cancer;M Nabholtz J;Rev Recent Clin Trials,2006
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Revolutionizing anticancer drug delivery: Exploring the potential of tamoxifen-loaded nanoformulations;Journal of Drug Delivery Science and Technology;2023-09
2. Recent developments in natural biopolymer based drug delivery systems;RSC Advances;2023
3. Polysaccharide nanoconjugates in drug delivery;Tailor-Made Polysaccharides in Drug Delivery;2023
4. Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells;Journal of Materials Science: Materials in Medicine;2022-02
5. Targeting Estrogen Receptor-Positive Breast Microtumors with Endoxifen-Conjugated, Hypoxia-Sensitive Polymersomes;ACS Omega;2021-10-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3